Recall Record

East Brunswick, NJ, United States

Strides Pharma Inc. recalls

9 recalls recorded since 2018, most recently on 2 March 2026. 3 are listed as ongoing. Status and classification are as published by the FDA.

Recalls9
Ongoing (FDA)3
Terminated or completed6
Class I (FDA)0

Ongoing Class II Drugs

Recall started
2 March 2026
Reason
Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.
Distribution
U.S.A. Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0390-2026

Ongoing Class II Drugs

Recall started
9 July 2025
Reason
Failed Dissolution Specifications.
Distribution
Product was distributed nationwide within the United States
Initiated
Voluntary: Firm initiated
Recall number
D-0546-2025

Ongoing Class II Drugs

Recall started
5 March 2025
Reason
Presence of foreign substance: Presence of Benzene.
Distribution
Nationwide in the U.S
Initiated
Voluntary: Firm initiated
Recall numbers
D-0294-2025, D-0293-2025

Terminated Class II Drugs

Recall started
29 December 2023
Terminated
1 July 2025
Reason
Failed Dissolution Specifications
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0260-2024

Terminated Class II Drugs

Recall started
26 June 2023
Terminated
15 May 2024
Reason
Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
Distribution
Nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall number
D-0895-2023

Terminated Class II Drugs

Recall started
19 July 2022
Terminated
21 June 2023
Reason
Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets
Distribution
US Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-1330-2022

Terminated Class II Drugs

Recall started
18 May 2022
Terminated
20 October 2023
Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-0973-2022, D-0974-2022, D-0972-2022

Terminated Class II Drugs

Recall started
27 September 2021
Terminated
26 October 2022
Reason
Failed Dissolution Specifications
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0006-2022

Terminated Class III Drugs

Recall started
22 December 2020
Terminated
26 January 2022
Reason
Failed Moisture Limits
Distribution
PA
Initiated
Voluntary: Firm initiated
Recall number
D-0180-2021

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.